Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of End-Stage Kidney Disease Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of End-Stage Kidney Disease Treatmentmarket, defines the market attractiveness level of End-Stage Kidney Disease Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of End-Stage Kidney Disease Treatment industry, describes the types of End-Stage Kidney Disease Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global End-Stage Kidney Disease Treatment market and the development prospects and opportunities of End-Stage Kidney Disease Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global End-Stage Kidney Disease Treatment market in Chapter 13.
By Player:
F Hoffmann-La Roche Ltd
BLR Bio LLC
Novartis AG
VESSL Therapeutics Ltd
Prolong Pharmaceuticals LLC
CTI BioPharma Corp
By Type:
MK-3866
Pacritinib
Sanguinate
Tesidolumab
Others
By End-User:
Clinic
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 End-Stage Kidney Disease Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 End-Stage Kidney Disease Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 End-Stage Kidney Disease Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 End-Stage Kidney Disease Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise End-Stage Kidney Disease Treatment Market Analysis and Outlook to 2022
-
7.1 Global End-Stage Kidney Disease Treatment Consumption (2017-2022)
-
7.2 United States End-Stage Kidney Disease Treatment Consumption (2017-2022)
-
7.3 Europe End-Stage Kidney Disease Treatment Consumption (2017-2022)
-
7.4 China End-Stage Kidney Disease Treatment Consumption (2017-2022)
-
7.5 Japan End-Stage Kidney Disease Treatment Consumption (2017-2022)
-
7.6 India End-Stage Kidney Disease Treatment Consumption (2017-2022)
-
7.7 South Korea End-Stage Kidney Disease Treatment Consumption (2017-2022)
8 Region and Country-wise End-Stage Kidney Disease Treatment Market Analysis and Outlook to 2028
-
8.1 Global End-Stage Kidney Disease Treatment Consumption Forecast (2022-2028)
-
8.2 United States End-Stage Kidney Disease Treatment Consumption Forecast (2022-2028)
-
8.3 Europe End-Stage Kidney Disease Treatment Consumption Forecast (2022-2028)
-
8.4 China End-Stage Kidney Disease Treatment Consumption Forecast (2022-2028)
-
8.5 Japan End-Stage Kidney Disease Treatment Consumption Forecast (2022-2028)
-
8.6 India End-Stage Kidney Disease Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea End-Stage Kidney Disease Treatment Consumption Forecast (2022-2028)
9 Global End-Stage Kidney Disease Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global End-Stage Kidney Disease Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global MK-3866 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pacritinib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Sanguinate Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Tesidolumab Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global End-Stage Kidney Disease Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global End-Stage Kidney Disease Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global End-Stage Kidney Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global MK-3866 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pacritinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Sanguinate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Tesidolumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global End-Stage Kidney Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global End-Stage Kidney Disease Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global End-Stage Kidney Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global End-Stage Kidney Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 End-Stage Kidney Disease Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global End-Stage Kidney Disease Treatment Market Competitive Analysis
-
14.1 F Hoffmann-La Roche Ltd
-
14.1.1 F Hoffmann-La Roche Ltd Company Details
-
14.1.2 F Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 F Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Product and Service
-
14.2 BLR Bio LLC
-
14.2.1 BLR Bio LLC Company Details
-
14.2.2 BLR Bio LLC End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 BLR Bio LLC End-Stage Kidney Disease Treatment Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG End-Stage Kidney Disease Treatment Product and Service
-
14.4 VESSL Therapeutics Ltd
-
14.4.1 VESSL Therapeutics Ltd Company Details
-
14.4.2 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Product and Service
-
14.5 Prolong Pharmaceuticals LLC
-
14.5.1 Prolong Pharmaceuticals LLC Company Details
-
14.5.2 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Product and Service
-
14.6 CTI BioPharma Corp
-
14.6.1 CTI BioPharma Corp Company Details
-
14.6.2 CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of End-Stage Kidney Disease Treatment
-
Figure End-Stage Kidney Disease Treatment Picture
-
Table Global End-Stage Kidney Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global End-Stage Kidney Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global End-Stage Kidney Disease Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global End-Stage Kidney Disease Treatment Consumption by Country (2017-2022)
-
Figure United States End-Stage Kidney Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe End-Stage Kidney Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure China End-Stage Kidney Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan End-Stage Kidney Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure India End-Stage Kidney Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea End-Stage Kidney Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global End-Stage Kidney Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States End-Stage Kidney Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe End-Stage Kidney Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China End-Stage Kidney Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan End-Stage Kidney Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India End-Stage Kidney Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea End-Stage Kidney Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MK-3866 Consumption and Growth Rate (2017-2022)
-
Figure Global Pacritinib Consumption and Growth Rate (2017-2022)
-
Figure Global Sanguinate Consumption and Growth Rate (2017-2022)
-
Figure Global Tesidolumab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global MK-3866 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pacritinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sanguinate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tesidolumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global End-Stage Kidney Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global End-Stage Kidney Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Product and Service
-
Table BLR Bio LLC (Foundation Year, Company Profile and etc.)
-
Table BLR Bio LLC End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table BLR Bio LLC End-Stage Kidney Disease Treatment Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG End-Stage Kidney Disease Treatment Product and Service
-
Table VESSL Therapeutics Ltd (Foundation Year, Company Profile and etc.)
-
Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Product and Service
-
Table Prolong Pharmaceuticals LLC (Foundation Year, Company Profile and etc.)
-
Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Product and Service
-
Table CTI BioPharma Corp (Foundation Year, Company Profile and etc.)
-
Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Product and Service
-
